AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 64 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,209,067 | +1533.9% | 80,874 | +511.4% | 0.00% | – |
| Q1 2022 | $74,000 | -18.7% | 13,228 | -31.5% | 0.00% | – |
| Q4 2021 | $91,000 | -67.8% | 19,300 | -57.9% | 0.00% | – |
| Q3 2021 | $283,000 | -57.4% | 45,800 | -54.6% | 0.00% | – |
| Q2 2021 | $664,000 | -46.4% | 100,863 | -40.5% | 0.00% | – |
| Q1 2021 | $1,239,000 | +481.7% | 169,417 | +371.8% | 0.00% | – |
| Q3 2020 | $213,000 | +153.6% | 35,912 | +120.2% | 0.00% | – |
| Q2 2020 | $84,000 | – | 16,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |